Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01979133 · ClinicalTrials.gov registry record · Phase 3
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
A Phase 3 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01979133 is a Phase 3 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT01979133, a Phase 3 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is being done to see if icariin will help with depression in patients with bipolar disorder and alcohol or cocaine use disorders. The pills used in this study contain 20% icariin.
Interventions
- DRUG Icariin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01979133
The ClinicalTrials.gov registry entry for NCT01979133 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Icariin is the first listed.
NCT01979133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01979133 about?
NCT01979133 is a clinical study titled "Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders". This study is being done to see if icariin will help with depression in patients with bipolar disorder and alcohol or cocaine use disorders. The pills used in this study contain 20% icariin.
What is the current status of trial NCT01979133?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2013-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01979133?
The interventions under investigation include: Icariin (DRUG).
Who is sponsoring clinical trial NCT01979133?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.